Advances in lipidomics revealed the crucial role of fatty acids in physiological and pathological conditions. Imbalances in fatty acid biodistribution might drive the development of canine cognitive dysfunction (CCD), a disabling disease requiring multidisciplinary treatments. There is a growing focus on nutraceuticals, being adjuvant therapies with negligible adverse events. This paper evaluates the effect of Neurogen Pet Ultra® supplementation in aging dogs with CCD.
No takes yet. Share an insight, caveat, or question.
Luana Clerico (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: